Guest Editorial: Interphex Focuses on Evolution of the Life Sciences - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Guest Editorial: Interphex Focuses on Evolution of the Life Sciences
Show blasts off this month in Philadelphia with more suppliers, new trends, and real-world solutions


Pharmaceutical Technology
Volume 3, Issue 32


RJ Palermo
INTERPHEX returns this month to Philadelphia, marking the first time back to the city since 2001. The move down the coast from New York presents a wide variety of new opportunities for 2008. Now entering its 29th year, INTERPHEX is once again prepared to act as a catalyst for change and innovation for the entire industry, offering attendees a show floor with more than 1000 suppliers, and an educational program in which thought leaders from across the industry will deliver real world solutions that can be applied as soon as conference participants return to their facilities.

For the second consecutive year, INTERPHEX 2008 will be co-located with Pharma MedDevice, our sister event focusing on the convergence and cross disciplines of the life sciences withpharmaceuticals, biologics, and medical devices. Other additions in 2008 include BIOTECHNICA America, which will showcase leading suppliers of tools and technologies used in process development, Phase I–III clinical trials, and clinical biological production. These areas of the show floor will be free to badge holders.


Interphex 2007 participants gather and stroll the exhibit hall.
The theme for INTERPHEX 2008 focuses on the evolution of the life sciences market. It's clear that the industry is evolving and so too are life sciences manufacturing and production. With science- based manufacturing, fewer drug approvals, personalized medicine, new combination drug devices and delivery systems, INTERPHEX 2008 and its supporting events reflect the changes we are dealing with every day. At the same time, INTERPHEX is sticking to its roots: pharmaceutical manufacturing.

As always, we have worked to deliver a gathering that addresses the current and future needs of our marketplace, and have developed content, a show floor, and an educational forum shaped to offer a valuable industry resource. With PharmaMedDevice in the same location, thought-provoking keynotes, and a split level venue of wall-to-wall exhibits, INTERPHEX 2008 has created a nearly soldout venue and a can't miss industry gathering. Below are few highlights.
  • Opening Keynote (Mar. 26): Biotech visionary G. Steven Burill presents a "20/20 vision of 2020."
  • Keynote (Mar. 27):From Innovation to Commercialization—this panel will feature senior executives from pharmaceutical, biopharmaceutical, and medical device companies will discuss innovations and collaborations across market segments and the future of the converging life sciences markets.
  • General session (Mar 28): From Pandemics to Bioterrorism—The Global Role of BioManufacturing in Global Healthcare. Join us for a provocative discussion of this real threat of pandemics and bioterrorism. Speakers will discuss the role and challenges of biopharmaceutical manufacturing professionals in case of attack.
  • Facility of the year: The show floor will feature category winners in facility integration, project execution, process innovation, and equipment innovation.
  • Life sciences career fair:Sponsored by ISPE and AAPS, companies looking to fill positions in a face-to-face platform will have the opportunity to do so.

Overall, life science professionals seeking the latest our industry has to offer will find it all in one place, over the course of three days in Philadelphia, March 26–28. Visit INTERPHEX 2008 to learn, network, and see the largest display of life science technology in North America.

RJ Palermo is Industry Vice-President for INTERPHEX 2008, tel. 203.850.5924,

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
20%
To all process for new products only
13%
To select process for new products only
25%
To select processes for both new and legacy products
20%
Do not use QbD
23%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
Overcoming the Challenges in Biopharmaceutical Stability Testing
PhRMA Dismayed by Special 301 Report
FindPharma Custom Search
Source: Pharmaceutical Technology,
Click here